Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.
Public ClinicalTrials.gov record NCT00798317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion.
Study identification
- NCT ID
- NCT00798317
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ThromboGenics
- Industry
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Interventions
- Ocriplasmin 125µg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- May 31, 2010
- Completion
- Jun 30, 2010
- Last update posted
- Dec 16, 2014
2008 – 2010
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Diagnostic Center | Campbell | California | 95008 | — |
| West Coast Retina Group, Inc | San Francisco | California | 94107 | — |
| California Retina Consultants | Santa Barbara | California | 93103 | — |
| Medeye | Miami | Florida | 33143 | — |
| Retina Specialists | Pensacola | Florida | 32503 | — |
| Paducah Retinal Center | Paducah | Kentucky | 42001 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Vision Research Center at Truman Medical Center | Kansas City | Missouri | 64108 | — |
| Deleware Valley Retina Associates | Lawrenceville | New Jersey | 08648 | — |
| Capital Region Retina | Albany | New York | 12206 | — |
| Southeast Clinical Research Assoicates, PA | Charlotte | North Carolina | 28210 | — |
| Dean A McGee Eye Institute | Oklahoma City | Oklahoma | 73104 | — |
| Scheie Eye Institute, Penn Eye Care | Philadelphia | Pennsylvania | 19104 | — |
| Black Hils regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Texas Retina Associates | Arlington | Texas | 76012 | — |
| Retina Research Center | Austin | Texas | 78705 | — |
| Retina Consultants | Fort Worth | Texas | 76104 | — |
| Medical Center Ophthalmology Assoc. | San Antonio | Texas | 78240 | — |
| Eye Care Associates | Tyler | Texas | 75701 | — |
| Vitreoretinal Associates | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00798317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00798317 live on ClinicalTrials.gov.